Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 11:41:10 +0200Thu, 04 Apr 2024 11:23:00 +0200Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 15, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dovatoHuman medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 15, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dovatoThu, 04 Apr 2024 11:23:00 +0200Human medicineDovato : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4909-en.pdfDovato : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4909-en.pdfThu, 04 Apr 2024 11:22:00 +0200Human medicine